Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future

dc.contributor.author	BENNETT, KATHLEEN	en
dc.date.accessioned	2016-07-12T13:16:21Z
dc.date.available	2016-07-12T13:16:21Z
dc.date.issued	2013	en
dc.date.submitted	2013	en
dc.identifier.citation	Godman, B. Persson, M. Miranda, J. Barbui, C. Bennie, M. Bennett, K. Bucsics, A. Simoens, S. Zara, C. Gustafsson, L. L., Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future, Clinical Therapeutics, 35, 8, 2013, 99 - 100	en
dc.identifier.other	Y	en
dc.description	PUBLISHED	en
dc.format.extent	99	en
dc.format.extent	100	en
dc.relation.ispartofseries	Clinical Therapeutics	en
dc.relation.ispartofseries	35	en
dc.relation.ispartofseries	8	en
dc.rights	Y	en
dc.title	Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future	en
dc.type	Journal Article	en
dc.type.supercollection	scholarly_publications	en
dc.type.supercollection	refereed_publications	en
dc.identifier.peoplefinderurl	http://people.tcd.ie/bennettk	en
dc.identifier.rssinternalid	92309	en
dc.rights.ecaccessrights	openAccess
dc.identifier.uri	http://hdl.handle.net/2262/76694

Browse